Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for urinary metabolic indices in patients with kidney stones
IRCT20260430069214N1Phase 3Completed
- Sponsor
- Yasouj University of Medical Sciences
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in nephrolithiasis comparing Atorvastatin plus standard treatment with Placebo plus standard treatment (2 arms). Primary endpoint: 24-hour urinary metabolic indices. Started Jun 2026; status: completed.
02
Drugs
atorvastatin
03
Conditions
nephrolithiasis
Beyond the preview
Go deeper on IRCT20260430069214N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260430069214N1.